{"country":"Ecuador","iso2":"EC","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":92,"new_today":0,"on_pages":92,"full_list":[],"page":1,"pages":1,"per_page":500,"html":"https://worldwide-corruption.com/database/ecuador/findings/fcpa-pattern/","records":[{"code":"W-04635","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · WB P173773 · Ecuador COVID-19 Emergency Response and Vaccination Project","buyer":"","amount":72012504.0,"currency":null,"records":1,"found":"2026-10-04","refs":["WB-1664334","2012-08-07","2021-10-06"],"id":"W-04635","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04635/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04635/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: PFE · SUB · EC · WB P173773 · Ecuador COVID-19 Emergency Response and Vaccination Project, 72,012,504.","facts":[["Company / subject","PFE · SUB · EC · WB P173773 · Ecuador COVID-19 Emergency Response and Vaccination Project",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","72,012,504",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-04635",null],["Reference","WB-1664334",null],["Reference","2012-08-07",null],["Reference","2021-10-06",null]],"summary":null,"entity":"f154fc8a"},{"code":"W-04618","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"SVA · SUB~ · EC · WB P173773 · Ecuador COVID-19 Emergency Response and Vaccination Project","buyer":"","amount":53005000.0,"currency":null,"records":1,"found":"2026-10-04","refs":["WB-1667973","2021-10-06"],"id":"W-04618","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04618/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04618/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: SVA · SUB~ · EC · WB P173773 · Ecuador COVID-19 Emergency Response and Vaccination Project, 53,005,000.","facts":[["Company / subject","SVA · SUB~ · EC · WB P173773 · Ecuador COVID-19 Emergency Response and Vaccination Project",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","53,005,000",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-04618",null],["Reference","WB-1667973",null],["Reference","2021-10-06",null]],"summary":null,"entity":"6eb76106"},{"code":"W-04644","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"AZN · SUB · EC · WB P173773 · Ecuador COVID-19 Emergency Response and Vaccination Project","buyer":"","amount":20166600.0,"currency":null,"records":1,"found":"2026-10-04","refs":["WB-1668677","2016-08-30","2021-10-06"],"id":"W-04644","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04644/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04644/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: AZN · SUB · EC · WB P173773 · Ecuador COVID-19 Emergency Response and Vaccination Project, 20,166,600.","facts":[["Company / subject","AZN · SUB · EC · WB P173773 · Ecuador COVID-19 Emergency Response and Vaccination Project",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","20,166,600",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-04644",null],["Reference","WB-1668677",null],["Reference","2016-08-30",null],["Reference","2021-10-06",null]],"summary":null,"entity":"918452e9"},{"code":"W-01622","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"WPP · SUB~ · EC · MINDSHARE DEL ECUADOR C. LTDA.","buyer":"","amount":3546373.56,"currency":null,"records":3,"found":"2026-10-04","refs":["ocds-5wno2w-RE-SEPS-004-2021-411160","ocds-5wno2w-RE-SC-MDMQ-11-2021-41357","ocds-5wno2w-RE-CSCD-PR-2024-001-1468"],"id":"W-01622","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01622/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01622/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'MINDSHARE ~0.72' «MINDSHARE DEL ECUADOR C. LTDA.» ↔ SEC WPP (CIK 806968, WPP plc): 3 non-competitive contracts at the buyer «SUPERINTENDENCIA DE ECONOMIA POPULAR Y SOLIDARIA», 3,546,374 USD (≈ $3,546,374); one bid, method limited (Comunicación Social – Proceso de Selección); OCID ocds-5wno2w-RE-SEPS-004-2021-411160, ocds-5wno2w-RE-SC-MDMQ-11-2021-41357, ocds-5wno2w-RE-CSCD-PR-2024-001-1468.","facts":[["Company / subject","WPP · SUB~ · EC · MINDSHARE DEL ECUADOR C. LTDA.",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","3,546,374",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-01622",null],["Reference","ocds-5wno2w-RE-SEPS-004-2021-411160",null],["Reference","ocds-5wno2w-RE-SC-MDMQ-11-2021-41357",null],["Reference","ocds-5wno2w-RE-CSCD-PR-2024-001-1468",null]],"summary":"looks like a subsidiary 'MINDSHARE ~0.72' «MINDSHARE DEL ECUADOR C. LTDA.» ↔ SEC WPP (CIK 806968, WPP plc): 3 non-competitive contracts at the buyer «SUPERINTENDENCIA DE ECONOMIA POPULAR Y SOLIDARIA», 3,546,374 USD (≈ $3,546,374); one bid, method limited (Comunicación Social – Proceso de Selección); OCID ocds-5wno2w-RE-SEPS-004-2021-411160, ocds-5wno2w-RE-SC-MDMQ-11-2021-41357, ocds-5wno2w-RE-CSCD-PR-2024-001-1468","entity":"aed1595f"},{"code":"W-02871","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"WPP · SUB~ · EC · PRESIDENCIA DE LA REPUBLICA","buyer":"","amount":2500000.0,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-RE-CSCD-PR-2024-001-1468"],"id":"W-02871","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02871/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02871/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'MINDSHARE ~0.72' «MINDSHARE DEL ECUADOR C. LTDA.» ↔ SEC WPP (CIK 806968, WPP plc): 1 non-competitive contracts at the buyer «PRESIDENCIA DE LA REPUBLICA», 2,500,000 USD (≈ $2,500,000); one bid; OCID ocds-5wno2w-RE-CSCD-PR-2024-001-1468.","facts":[["Company / subject","WPP · SUB~ · EC · PRESIDENCIA DE LA REPUBLICA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","2,500,000",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-02871",null],["Reference","ocds-5wno2w-RE-CSCD-PR-2024-001-1468",null]],"summary":"looks like a subsidiary 'MINDSHARE ~0.72' «MINDSHARE DEL ECUADOR C. LTDA.» ↔ SEC WPP (CIK 806968, WPP plc): 1 non-competitive contracts at the buyer «PRESIDENCIA DE LA REPUBLICA», 2,500,000 USD (≈ $2,500,000); one bid; OCID ocds-5wno2w-RE-CSCD-PR-2024-001-1468","entity":"c10fdccf"},{"code":"W-01618","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"SNY · SUB~ · EC · SANOFI - AVENTIS DEL ECUADOR S.A.","buyer":"","amount":1990531.0599999998,"currency":null,"records":5,"found":"2026-10-04","refs":["ocds-5wno2w-RE-HEEE-002-2021-52558","ocds-5wno2w-RE-HEEE-006-2021-52558","ocds-5wno2w-RE-HEJCA-F-016-2021-87497","ocds-5wno2w-RE-HGFO-008-2021-54538","ocds-5wno2w-RE-HBO-014-2021-YA-40576","2018-09-04"],"id":"W-01618","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01618/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01618/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'SANOFI AVENTIS AUSTRALIA ~0.73' «SANOFI - AVENTIS DEL ECUADOR S.A.» ↔ SEC SNY (CIK 1121404, Sanofi): 5 non-competitive contracts at the buyer «Hospital Eugenio Espejo», 1,990,531 USD (≈ $1,990,531); one bid; OCID ocds-5wno2w-RE-HEEE-002-2021-52558, ocds-5wno2w-RE-HEEE-006-2021-52558, ocds-5wno2w-RE-HEJCA-F-016-2021-87497, ocds-5wno2w-RE-HGFO-008-2021-54538, ocds-5wno2w-RE-HBO-014-2021-YA-40576; ⚑ REPEAT: already sanctioned SEC by FCPA (2018-09-04 Sanofi).","facts":[["Company / subject","SNY · SUB~ · EC · SANOFI - AVENTIS DEL ECUADOR S.A.",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,990,531",null],["Records behind the indicator","5",null],["Found","4 October 2026",null],["Code","W-01618",null],["Reference","ocds-5wno2w-RE-HEEE-002-2021-52558",null],["Reference","ocds-5wno2w-RE-HEEE-006-2021-52558",null],["Reference","ocds-5wno2w-RE-HEJCA-F-016-2021-87497",null],["Reference","ocds-5wno2w-RE-HGFO-008-2021-54538",null],["Reference","ocds-5wno2w-RE-HBO-014-2021-YA-40576",null],["Reference","2018-09-04",null]],"summary":"looks like a subsidiary 'SANOFI AVENTIS AUSTRALIA ~0.73' «SANOFI - AVENTIS DEL ECUADOR S.A.» ↔ SEC SNY (CIK 1121404, Sanofi): 5 non-competitive contracts at the buyer «Hospital Eugenio Espejo», 1,990,531 USD (≈ $1,990,531); one bid; OCID ocds-5wno2w-RE-HEEE-002-2021-52558, ocds-5wno2w-RE-HEEE-006-2021-52558, ocds-5wno2w-RE-HEJCA-F-016-2021-87497, ocds-5wno2w-RE-HGFO-008-2021-54538, ocds-5wno2w-RE-HBO-014-2021-YA-40576; ⚑ REPEAT: already sanctioned SEC by FCPA (2018-09-04 Sanofi)","entity":"742b1029"},{"code":"W-01619","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA","buyer":"","amount":1214561.8,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM2-628-2016","ocds-5wno2w-RE-HEJCA-F-021-2021-87497","ocds-5wno2w-SIE-HEJCA-F-43-2021-87497","ocds-5wno2w-CE-20250002777711-87497","2020-06-25","2016-03-23"],"id":"W-01619","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01619/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01619/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA», 1,214,562 USD (≈ $1,214,562); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE; OCID ocds-5wno2w-RE-HEJCA-F-021-2021-87497, ocds-5wno2w-SIE-HEJCA-F-43-2021-87497, ocds-5wno2w-CE-20250002777711-87497; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG).","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,214,562",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-01619",null],["Reference","SICM2-628-2016",null],["Reference","ocds-5wno2w-RE-HEJCA-F-021-2021-87497",null],["Reference","ocds-5wno2w-SIE-HEJCA-F-43-2021-87497",null],["Reference","ocds-5wno2w-CE-20250002777711-87497",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA», 1,214,562 USD (≈ $1,214,562); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE; OCID ocds-5wno2w-RE-HEJCA-F-021-2021-87497, ocds-5wno2w-SIE-HEJCA-F-43-2021-87497, ocds-5wno2w-CE-20250002777711-87497; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG)","entity":"faaf820c"},{"code":"W-01592","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · GLAXOSMITHKLINE ECUADOR S A","buyer":"","amount":1088142.5350000001,"currency":null,"records":93,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20210001952653-836661","ocds-5wno2w-CE-20210001954739-72588","ocds-5wno2w-CE-20210001956299-107425","ocds-5wno2w-CE-20210001955849-2528","ocds-5wno2w-CE-20210001956825-2763","ocds-5wno2w-CE-20210001957648-818925","ocds-5wno2w-CE-20210001961551-104249"],"id":"W-01592","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01592/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01592/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 93 non-competitive contracts at the buyer «FUNDACION MUNICIPAL DE LA MUJER Y EL NIÑO DE CUENCA», 1,088,143 USD (≈ $1,088,143); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTO; OCID ocds-5wno2w-CE-20210001952653-836661, ocds-5wno2w-CE-20210001954739-72588, ocds-5wno2w-CE-20210001956299-107425, ocds-5wno2w-CE-20210001955849-2528, ocds-5wno2w-CE-20210001956825-2763, ocds-5wno2w-CE-20210001957648-818925, ocds-5wno2w-CE-20210001961551-104249, ocds-5wno2w-CE-20210001966081-59830, ocds-5wno2w-CE-20210001967473-2758, ocds-5wno2w-CE-20210002010396-380339, ocds-5wno2w-CE-2021000201092.","facts":[["Company / subject","GSK · SUB~ · EC · GLAXOSMITHKLINE ECUADOR S A",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,088,143",null],["Records behind the indicator","93",null],["Found","4 October 2026",null],["Code","W-01592",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20210001952653-836661",null],["Reference","ocds-5wno2w-CE-20210001954739-72588",null],["Reference","ocds-5wno2w-CE-20210001956299-107425",null],["Reference","ocds-5wno2w-CE-20210001955849-2528",null],["Reference","ocds-5wno2w-CE-20210001956825-2763",null],["Reference","ocds-5wno2w-CE-20210001957648-818925",null],["Reference","ocds-5wno2w-CE-20210001961551-104249",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 93 non-competitive contracts at the buyer «FUNDACION MUNICIPAL DE LA MUJER Y EL NIÑO DE CUENCA», 1,088,143 USD (≈ $1,088,143); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTO; OCID ocds-5wno2w-CE-20210001952653-836661, ocds-5wno2w-CE-20210001954739-72588, ocds-5wno2w-CE-20210001956299-107425, ocds-5wno2w-CE-20210001955849-2528, ocds-5wno2w-CE-20210001956825-2763, ocds-5wno2w-CE-20210001957648-818925, ocds-5wno2w-CE-20210001961551-104249, ocds-5wno2w-CE-20210001966081-59830, ocds-5wno2w-CE-20210001967473-2758, ocds-5wno2w-CE-20210002010396-380339, ocds-5wno2w-CE-2021000201092","entity":"569d257c"},{"code":"W-02855","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"WPP · SUB~ · EC · GOBIERNO AUTONOMO DESCENTRALIZADO DEL DISTRITO METROPOLITANO DE QUITO","buyer":"","amount":980000.0,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-RE-SC-MDMQ-11-2021-41357","2021-10-06"],"id":"W-02855","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02855/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02855/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: WPP · SUB~ · EC · GOBIERNO AUTONOMO DESCENTRALIZADO DEL DISTRITO METROPOLITANO DE QUITO, 980,000.","facts":[["Company / subject","WPP · SUB~ · EC · GOBIERNO AUTONOMO DESCENTRALIZADO DEL DISTRITO METROPOLITANO DE QUITO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","980,000",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-02855",null],["Reference","ocds-5wno2w-RE-SC-MDMQ-11-2021-41357",null],["Reference","2021-10-06",null]],"summary":null,"entity":"74722591"},{"code":"W-02847","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"SNY · SUB~ · EC · Hospital Eugenio Espejo","buyer":"","amount":950410.8999999999,"currency":null,"records":2,"found":"2026-10-04","refs":["ocds-5wno2w-RE-HEEE-002-2021-52558","ocds-5wno2w-RE-HEEE-006-2021-52558","2018-09-04","2021-10-06"],"id":"W-02847","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02847/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02847/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: SNY · SUB~ · EC · Hospital Eugenio Espejo, 950,411.","facts":[["Company / subject","SNY · SUB~ · EC · Hospital Eugenio Espejo",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","950,411",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02847",null],["Reference","ocds-5wno2w-RE-HEEE-002-2021-52558",null],["Reference","ocds-5wno2w-RE-HEEE-006-2021-52558",null],["Reference","2018-09-04",null],["Reference","2021-10-06",null]],"summary":null,"entity":"7d3f0131"},{"code":"W-01645","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · MINISTERIO DE SALUD PUBLICA MATRIZ","buyer":"","amount":917388.16,"currency":null,"records":6,"found":"2026-10-04","refs":["SICM-197-2016-C","ocds-5wno2w-CE-20260002969199-2455","ocds-5wno2w-CE-20260002969208-2455","ocds-5wno2w-CE-20260002969214-2455","ocds-5wno2w-CE-20260002969494-2455","ocds-5wno2w-CE-20260002969646-2455","ocds-5wno2w-CE-20260003091744-2455","2012-08-07"],"id":"W-01645","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01645/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01645/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER PFE CIA.LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 6 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA MATRIZ», 917,388 USD (≈ $917,388); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20260002969199-2455, ocds-5wno2w-CE-20260002969208-2455, ocds-5wno2w-CE-20260002969214-2455, ocds-5wno2w-CE-20260002969494-2455, ocds-5wno2w-CE-20260002969646-2455, ocds-5wno2w-CE-20260003091744-2455; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","PFE · SUB · EC · MINISTERIO DE SALUD PUBLICA MATRIZ",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","917,388",null],["Records behind the indicator","6",null],["Found","4 October 2026",null],["Code","W-01645",null],["Reference","SICM-197-2016-C",null],["Reference","ocds-5wno2w-CE-20260002969199-2455",null],["Reference","ocds-5wno2w-CE-20260002969208-2455",null],["Reference","ocds-5wno2w-CE-20260002969214-2455",null],["Reference","ocds-5wno2w-CE-20260002969494-2455",null],["Reference","ocds-5wno2w-CE-20260002969646-2455",null],["Reference","ocds-5wno2w-CE-20260003091744-2455",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER PFE CIA.LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 6 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA MATRIZ», 917,388 USD (≈ $917,388); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20260002969199-2455, ocds-5wno2w-CE-20260002969208-2455, ocds-5wno2w-CE-20260002969214-2455, ocds-5wno2w-CE-20260002969494-2455, ocds-5wno2w-CE-20260002969646-2455, ocds-5wno2w-CE-20260003091744-2455; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"d372ed93"},{"code":"W-04617","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"SVA · AGENT · EC · DHL GLOBAL FORWARDING ECUADOR S.A","buyer":"","amount":759322.48,"currency":null,"records":1,"found":"2026-10-04","refs":["WB-1702020","2021-10-06"],"id":"W-04617","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04617/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04617/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: SVA · AGENT · EC · DHL GLOBAL FORWARDING ECUADOR S.A, 759,322.","facts":[["Company / subject","SVA · AGENT · EC · DHL GLOBAL FORWARDING ECUADOR S.A",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","759,322",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-04617",null],["Reference","WB-1702020",null],["Reference","2021-10-06",null]],"summary":null,"entity":"30cbe113"},{"code":"W-01632","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GM · SUB · EC · Municipalidad de Guayaquil","buyer":"","amount":729824.0,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-MIMG-100-2021-44856","2021-10-06"],"id":"W-01632","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01632/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01632/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: GM · SUB · EC · Municipalidad de Guayaquil, 729,824.","facts":[["Company / subject","GM · SUB · EC · Municipalidad de Guayaquil",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","729,824",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01632",null],["Reference","ocds-5wno2w-SIE-MIMG-100-2021-44856",null],["Reference","2021-10-06",null]],"summary":null,"entity":"e9ec3710"},{"code":"W-01600","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL DE ESPECIALIDADES - TEODORO MALDONADO CARBO","buyer":"","amount":727468.4199999999,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM2-628-2016","ocds-5wno2w-CE-20210001959904-2810","ocds-5wno2w-SIE-HTMC-060-2021-2810","ocds-5wno2w-RE-PU-HTMC-2025-002-2810","2020-06-25","2016-03-23"],"id":"W-01600","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01600/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01600/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES - TEODORO MALDONADO CARBO», 727,468 USD (≈ $727,468); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE; OCID ocds-5wno2w-CE-20210001959904-2810, ocds-5wno2w-SIE-HTMC-060-2021-2810, ocds-5wno2w-RE-PU-HTMC-2025-002-2810; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG).","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL DE ESPECIALIDADES - TEODORO MALDONADO CARBO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","727,468",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-01600",null],["Reference","SICM2-628-2016",null],["Reference","ocds-5wno2w-CE-20210001959904-2810",null],["Reference","ocds-5wno2w-SIE-HTMC-060-2021-2810",null],["Reference","ocds-5wno2w-RE-PU-HTMC-2025-002-2810",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES - TEODORO MALDONADO CARBO», 727,468 USD (≈ $727,468); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE; OCID ocds-5wno2w-CE-20210001959904-2810, ocds-5wno2w-SIE-HTMC-060-2021-2810, ocds-5wno2w-RE-PU-HTMC-2025-002-2810; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG)","entity":"d0cac662"},{"code":"W-01647","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN","buyer":"","amount":718291.2,"currency":null,"records":1,"found":"2026-10-04","refs":["SICM2-628-2016","ocds-5wno2w-CE-20260003105157-54651","2020-06-25","2016-03-23"],"id":"W-01647","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01647/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01647/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 1 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN», 718,291 USD (≈ $718,291); method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20260003105157-54651; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","718,291",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01647",null],["Reference","SICM2-628-2016",null],["Reference","ocds-5wno2w-CE-20260003105157-54651",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 1 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN», 718,291 USD (≈ $718,291); method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20260003105157-54651; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"21869ad5"},{"code":"W-02848","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"SNY · SUB~ · EC · HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA","buyer":"","amount":617519.76,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-RE-HEJCA-F-016-2021-87497","2018-09-04","2021-10-06"],"id":"W-02848","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02848/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02848/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: SNY · SUB~ · EC · HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA, 617,520.","facts":[["Company / subject","SNY · SUB~ · EC · HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","617,520",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-02848",null],["Reference","ocds-5wno2w-RE-HEJCA-F-016-2021-87497",null],["Reference","2018-09-04",null],["Reference","2021-10-06",null]],"summary":null,"entity":"f5283ba7"},{"code":"W-01646","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · MINISTERIO DE SALUD PUBLICA MATRIZ","buyer":"","amount":591637.2,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM2-628-2016","ocds-5wno2w-CE-20260002969231-2455","ocds-5wno2w-CE-20260003091723-2455","2020-06-25","2016-03-23"],"id":"W-01646","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01646/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01646/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA MATRIZ», 591,637 USD (≈ $591,637); method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20260002969231-2455, ocds-5wno2w-CE-20260003091723-2455; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · MINISTERIO DE SALUD PUBLICA MATRIZ",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","591,637",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01646",null],["Reference","SICM2-628-2016",null],["Reference","ocds-5wno2w-CE-20260002969231-2455",null],["Reference","ocds-5wno2w-CE-20260003091723-2455",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA MATRIZ», 591,637 USD (≈ $591,637); method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20260002969231-2455, ocds-5wno2w-CE-20260003091723-2455; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"9afac2d3"},{"code":"W-01601","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES - TEODORO MALDONADO CARBO","buyer":"","amount":575036.28,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-389-2016","ocds-5wno2w-CE-20210001959905-2810","ocds-5wno2w-CE-20210001959322-2810","2012-08-07","2021-10-06"],"id":"W-01601","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01601/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01601/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES - TEODORO MALDONADO CARBO, 575,036.","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES - TEODORO MALDONADO CARBO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","575,036",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01601",null],["Reference","SICM-389-2016",null],["Reference","ocds-5wno2w-CE-20210001959905-2810",null],["Reference","ocds-5wno2w-CE-20210001959322-2810",null],["Reference","2012-08-07",null],["Reference","2021-10-06",null]],"summary":null,"entity":"a0c87f22"},{"code":"W-02873","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · INSTITUTO ECUATORIANO DE SEGURIDAD SOCIAL","buyer":"","amount":529052.51,"currency":null,"records":1,"found":"2026-10-04","refs":["SICM-486-2022","ocds-5wno2w-CE-20260002985852-39594"],"id":"W-02873","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02873/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02873/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 1 non-competitive contracts at the buyer «INSTITUTO ECUATORIANO DE SEGURIDAD SOCIAL», 529,053 USD (≈ $529,053); method direct (Catálogo electrónico - Compra directa en el convenio SICM-486-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20260002985852-39594; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · INSTITUTO ECUATORIANO DE SEGURIDAD SOCIAL",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","529,053",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-02873",null],["Reference","SICM-486-2022",null],["Reference","ocds-5wno2w-CE-20260002985852-39594",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 1 non-competitive contracts at the buyer «INSTITUTO ECUATORIANO DE SEGURIDAD SOCIAL», 529,053 USD (≈ $529,053); method direct (Catálogo electrónico - Compra directa en el convenio SICM-486-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20260002985852-39594; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"7d2d7a9b"},{"code":"W-01595","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"MRK · SUB · EC · ISSFA","buyer":"","amount":447040.8,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-359-2016-C","ocds-5wno2w-CE-20210001953576-2803","ocds-5wno2w-CE-20220002131084-2803"],"id":"W-01595","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01595/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01595/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «MERCK SHARP AND DOHME (I.A) LLC» ↔ SEC MRK (CIK 310158, Merck & Co., Inc.): 2 non-competitive contracts at the buyer «ISSFA», 447,041 USD (≈ $447,041); method direct (Catálogo electrónico - Compra directa en el convenio SICM-359-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001953576-2803, ocds-5wno2w-CE-20220002131084-2803; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","MRK · SUB · EC · ISSFA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","447,041",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01595",null],["Reference","SICM-359-2016-C",null],["Reference","ocds-5wno2w-CE-20210001953576-2803",null],["Reference","ocds-5wno2w-CE-20220002131084-2803",null]],"summary":"subsidiary/issuer «MERCK SHARP AND DOHME (I.A) LLC» ↔ SEC MRK (CIK 310158, Merck & Co., Inc.): 2 non-competitive contracts at the buyer «ISSFA», 447,041 USD (≈ $447,041); method direct (Catálogo electrónico - Compra directa en el convenio SICM-359-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001953576-2803, ocds-5wno2w-CE-20220002131084-2803; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"e4693f4e"},{"code":"W-01629","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"LIN · SUB · EC · HOSPITAL GENERAL IBARRA","buyer":"","amount":407299.75,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-015-HGI-2021-3260","2021-10-06"],"id":"W-01629","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01629/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01629/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: LIN · SUB · EC · HOSPITAL GENERAL IBARRA, 407,300.","facts":[["Company / subject","LIN · SUB · EC · HOSPITAL GENERAL IBARRA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","407,300",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01629",null],["Reference","ocds-5wno2w-SIE-015-HGI-2021-3260",null],["Reference","2021-10-06",null]],"summary":null,"entity":"481d1f63"},{"code":"W-01599","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA EL BATAN","buyer":"","amount":401770.5384,"currency":null,"records":1,"found":"2026-10-04","refs":["SICM-198-2016-C","ocds-5wno2w-CE-20210001958047-2808","2012-08-07","2021-10-06"],"id":"W-01599","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01599/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01599/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: PFE · SUB · EC · CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA EL BATAN, 401,771.","facts":[["Company / subject","PFE · SUB · EC · CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA EL BATAN",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","401,771",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01599",null],["Reference","SICM-198-2016-C",null],["Reference","ocds-5wno2w-CE-20210001958047-2808",null],["Reference","2012-08-07",null],["Reference","2021-10-06",null]],"summary":null,"entity":"d6a5d417"},{"code":"W-01633","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL EUGENIO ESPEJO","buyer":"","amount":376601.38,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-093-2022","ocds-5wno2w-CE-20240002555547-52558","ocds-5wno2w-CE-20240002572905-52558","2020-06-25","2016-03-23"],"id":"W-01633","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01633/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01633/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «HOSPITAL EUGENIO ESPEJO», 376,601 USD (≈ $376,601); method direct (Catálogo electrónico - Compra directa en el convenio SICM-093-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20240002555547-52558, ocds-5wno2w-CE-20240002572905-52558; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL EUGENIO ESPEJO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","376,601",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01633",null],["Reference","SICM-093-2022",null],["Reference","ocds-5wno2w-CE-20240002555547-52558",null],["Reference","ocds-5wno2w-CE-20240002572905-52558",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «HOSPITAL EUGENIO ESPEJO», 376,601 USD (≈ $376,601); method direct (Catálogo electrónico - Compra directa en el convenio SICM-093-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20240002555547-52558, ocds-5wno2w-CE-20240002572905-52558; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"4648e4ab"},{"code":"W-01634","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL GENERAL MANTA","buyer":"","amount":362351.52,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-197-2016-C","ocds-5wno2w-CE-20240002568171-74622","ocds-5wno2w-CE-20240002568419-74622","2012-08-07"],"id":"W-01634","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01634/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01634/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER CIA. LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 2 non-competitive contracts at the buyer «HOSPITAL GENERAL MANTA», 362,352 USD (≈ $362,352); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20240002568171-74622, ocds-5wno2w-CE-20240002568419-74622; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL GENERAL MANTA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","362,352",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01634",null],["Reference","SICM-197-2016-C",null],["Reference","ocds-5wno2w-CE-20240002568171-74622",null],["Reference","ocds-5wno2w-CE-20240002568419-74622",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER CIA. LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 2 non-competitive contracts at the buyer «HOSPITAL GENERAL MANTA», 362,352 USD (≈ $362,352); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20240002568171-74622, ocds-5wno2w-CE-20240002568419-74622; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"61080318"},{"code":"W-01602","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · ISSFA","buyer":"","amount":349283.16000000003,"currency":null,"records":4,"found":"2026-10-04","refs":["SICM-389-2016","ocds-5wno2w-CE-20210001959764-2803","ocds-5wno2w-CE-20210001959765-2803","ocds-5wno2w-SIE-ISSFA-2021-018-2803","ocds-5wno2w-CE-20250002899808-2803","2012-08-07"],"id":"W-01602","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01602/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01602/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER PFE CIA.LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 4 non-competitive contracts at the buyer «ISSFA», 349,283 USD (≈ $349,283); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-389-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE US; OCID ocds-5wno2w-CE-20210001959764-2803, ocds-5wno2w-CE-20210001959765-2803, ocds-5wno2w-SIE-ISSFA-2021-018-2803, ocds-5wno2w-CE-20250002899808-2803; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer).","facts":[["Company / subject","PFE · SUB · EC · ISSFA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","349,283",null],["Records behind the indicator","4",null],["Found","4 October 2026",null],["Code","W-01602",null],["Reference","SICM-389-2016",null],["Reference","ocds-5wno2w-CE-20210001959764-2803",null],["Reference","ocds-5wno2w-CE-20210001959765-2803",null],["Reference","ocds-5wno2w-SIE-ISSFA-2021-018-2803",null],["Reference","ocds-5wno2w-CE-20250002899808-2803",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER PFE CIA.LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 4 non-competitive contracts at the buyer «ISSFA», 349,283 USD (≈ $349,283); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-389-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE US; OCID ocds-5wno2w-CE-20210001959764-2803, ocds-5wno2w-CE-20210001959765-2803, ocds-5wno2w-SIE-ISSFA-2021-018-2803, ocds-5wno2w-CE-20250002899808-2803; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer)","entity":"a08f7e94"},{"code":"W-01630","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA","buyer":"","amount":345705.72,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-390-2016","ocds-5wno2w-SIE-HEJCA-F-42-2021-87497","ocds-5wno2w-CE-20240002566812-87497","ocds-5wno2w-CE-20240002566491-87497","2012-08-07"],"id":"W-01630","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01630/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01630/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER PFE CIA.LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 3 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA», 345,706 USD (≈ $345,706); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-390-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE US; OCID ocds-5wno2w-SIE-HEJCA-F-42-2021-87497, ocds-5wno2w-CE-20240002566812-87497, ocds-5wno2w-CE-20240002566491-87497; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer).","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","345,706",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-01630",null],["Reference","SICM-390-2016",null],["Reference","ocds-5wno2w-SIE-HEJCA-F-42-2021-87497",null],["Reference","ocds-5wno2w-CE-20240002566812-87497",null],["Reference","ocds-5wno2w-CE-20240002566491-87497",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER PFE CIA.LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 3 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA», 345,706 USD (≈ $345,706); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-390-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE US; OCID ocds-5wno2w-SIE-HEJCA-F-42-2021-87497, ocds-5wno2w-CE-20240002566812-87497, ocds-5wno2w-CE-20240002566491-87497; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer)","entity":"d8134898"},{"code":"W-04650","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"MH · SUB · EC · WB P152096 · Supporting Education Reform in Targeted Circuits","buyer":"","amount":340289.6,"currency":null,"records":1,"found":"2026-10-04","refs":["WB-1637505","2021-10-06"],"id":"W-04650","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04650/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-04650/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: MH · SUB · EC · WB P152096 · Supporting Education Reform in Targeted Circuits, 340,290.","facts":[["Company / subject","MH · SUB · EC · WB P152096 · Supporting Education Reform in Targeted Circuits",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","340,290",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-04650",null],["Reference","WB-1637505",null],["Reference","2021-10-06",null]],"summary":null,"entity":"b1b4dc70"},{"code":"W-01617","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"DE · AGENT · EC · MOTORES Y TRACTORES MOTRAC S.A.","buyer":"","amount":319613.02999999997,"currency":null,"records":7,"found":"2026-10-04","refs":["ocds-5wno2w-RE-EMAPALA-2021-001-793125","ocds-5wno2w-RE-GADPC-2021-OO2-89262","ocds-5wno2w-RE-GPI-005-2021-12001","ocds-5wno2w-RE-RA-GADSANTIAGO-2024-001-124958","ocds-5wno2w-RE-RA-GADPR-JADAN-2025-00001-100560"],"id":"W-01617","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01617/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01617/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: intermediary «MOTORES Y TRACTORES MOTRAC S.A.» supplies the brand DEERE ↔ SEC DE (CIK 315189, DEERE & CO): 7 non-competitive contracts, 319,613 USD (≈ $319,613); one bid; OCID ocds-5wno2w-RE-EMAPALA-2021-001-793125, ocds-5wno2w-RE-GADPC-2021-OO2-89262, ocds-5wno2w-RE-GPI-005-2021-12001, ocds-5wno2w-RE-RA-GADSANTIAGO-2024-001-124958, ocds-5wno2w-RE-RA-GADPR-JADAN-2025-00001-100560.","facts":[["Company / subject","DE · AGENT · EC · MOTORES Y TRACTORES MOTRAC S.A.",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","319,613",null],["Records behind the indicator","7",null],["Found","4 October 2026",null],["Code","W-01617",null],["Reference","ocds-5wno2w-RE-EMAPALA-2021-001-793125",null],["Reference","ocds-5wno2w-RE-GADPC-2021-OO2-89262",null],["Reference","ocds-5wno2w-RE-GPI-005-2021-12001",null],["Reference","ocds-5wno2w-RE-RA-GADSANTIAGO-2024-001-124958",null],["Reference","ocds-5wno2w-RE-RA-GADPR-JADAN-2025-00001-100560",null]],"summary":"intermediary «MOTORES Y TRACTORES MOTRAC S.A.» supplies the brand DEERE ↔ SEC DE (CIK 315189, DEERE & CO): 7 non-competitive contracts, 319,613 USD (≈ $319,613); one bid; OCID ocds-5wno2w-RE-EMAPALA-2021-001-793125, ocds-5wno2w-RE-GADPC-2021-OO2-89262, ocds-5wno2w-RE-GPI-005-2021-12001, ocds-5wno2w-RE-RA-GADSANTIAGO-2024-001-124958, ocds-5wno2w-RE-RA-GADPR-JADAN-2025-00001-100560","entity":"d5b931f5"},{"code":"W-01598","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL GENERAL MACHALA","buyer":"","amount":311821.9104,"currency":null,"records":1,"found":"2026-10-04","refs":["SICM-198-2016-C","ocds-5wno2w-CE-20210001956835-2763","2012-08-07","2021-10-06"],"id":"W-01598","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01598/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01598/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: PFE · SUB · EC · HOSPITAL GENERAL MACHALA, 311,822.","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL GENERAL MACHALA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","311,822",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01598",null],["Reference","SICM-198-2016-C",null],["Reference","ocds-5wno2w-CE-20210001956835-2763",null],["Reference","2012-08-07",null],["Reference","2021-10-06",null]],"summary":null,"entity":"614e8c3d"},{"code":"W-02849","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"SNY · SUB~ · EC · HOSPITAL GENERAL FRANCISCO DE ORELLANA","buyer":"","amount":281733.6,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-RE-HGFO-008-2021-54538","2018-09-04","2021-10-06"],"id":"W-02849","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02849/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02849/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: SNY · SUB~ · EC · HOSPITAL GENERAL FRANCISCO DE ORELLANA, 281,734.","facts":[["Company / subject","SNY · SUB~ · EC · HOSPITAL GENERAL FRANCISCO DE ORELLANA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","281,734",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-02849",null],["Reference","ocds-5wno2w-RE-HGFO-008-2021-54538",null],["Reference","2018-09-04",null],["Reference","2021-10-06",null]],"summary":null,"entity":"b33d4019"},{"code":"W-01626","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"BAX · SUB~ · EC · BAXTER ECUADOR S.A.","buyer":"","amount":263178.97,"currency":null,"records":2,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-HQ-INSU-029-2020-20291","ocds-5wno2w-SIEB-HEFFAA-065-2021-43246"],"id":"W-01626","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01626/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01626/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BAXTER ~0.76' «BAXTER ECUADOR S.A.» ↔ SEC BAX (CIK 10456, BAXTER INTERNATIONAL INC): 2 non-competitive contracts at the buyer «Hospital Quito No.1 de la Policia Nacional», 263,179 USD (≈ $263,179); one bid; OCID ocds-5wno2w-SIE-HQ-INSU-029-2020-20291, ocds-5wno2w-SIEB-HEFFAA-065-2021-43246; buyer — security/fiscal body.","facts":[["Company / subject","BAX · SUB~ · EC · BAXTER ECUADOR S.A.",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","263,179",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01626",null],["Reference","ocds-5wno2w-SIE-HQ-INSU-029-2020-20291",null],["Reference","ocds-5wno2w-SIEB-HEFFAA-065-2021-43246",null]],"summary":"looks like a subsidiary 'BAXTER ~0.76' «BAXTER ECUADOR S.A.» ↔ SEC BAX (CIK 10456, BAXTER INTERNATIONAL INC): 2 non-competitive contracts at the buyer «Hospital Quito No.1 de la Policia Nacional», 263,179 USD (≈ $263,179); one bid; OCID ocds-5wno2w-SIE-HQ-INSU-029-2020-20291, ocds-5wno2w-SIEB-HEFFAA-065-2021-43246; buyer — security/fiscal body","entity":"6435e476"},{"code":"W-01621","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · ISSFA","buyer":"","amount":227435.4,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-093-2022","ocds-5wno2w-RE-ISSFA-2021-012-2803","ocds-5wno2w-RE-ISSFA-2021-022-2803","ocds-5wno2w-CE-20240002570115-2803","2020-06-25","2016-03-23"],"id":"W-01621","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01621/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01621/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «ISSFA», 227,435 USD (≈ $227,435); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-093-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS; OCID ocds-5wno2w-RE-ISSFA-2021-012-2803, ocds-5wno2w-RE-ISSFA-2021-022-2803, ocds-5wno2w-CE-20240002570115-2803; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG).","facts":[["Company / subject","NVS · SUB · EC · ISSFA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","227,435",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-01621",null],["Reference","SICM-093-2022",null],["Reference","ocds-5wno2w-RE-ISSFA-2021-012-2803",null],["Reference","ocds-5wno2w-RE-ISSFA-2021-022-2803",null],["Reference","ocds-5wno2w-CE-20240002570115-2803",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «ISSFA», 227,435 USD (≈ $227,435); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-093-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS; OCID ocds-5wno2w-RE-ISSFA-2021-012-2803, ocds-5wno2w-RE-ISSFA-2021-022-2803, ocds-5wno2w-CE-20240002570115-2803; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG)","entity":"2b9c709e"},{"code":"W-01642","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES FUERZAS ARMADAS NO. 1","buyer":"","amount":219991.38,"currency":null,"records":2,"found":"2026-10-04","refs":["ocds-5wno2w-RE-PU-HE-1-2024-016-43246","ocds-5wno2w-SIE-HE-1-2025-020-43246","2012-08-07"],"id":"W-01642","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01642/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01642/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER CIA. LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 2 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES FUERZAS ARMADAS NO. 1», 219,991 USD (≈ $219,991); one bid; OCID ocds-5wno2w-RE-PU-HE-1-2024-016-43246, ocds-5wno2w-SIE-HE-1-2025-020-43246; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); buyer — security/fiscal body.","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES FUERZAS ARMADAS NO. 1",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","219,991",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01642",null],["Reference","ocds-5wno2w-RE-PU-HE-1-2024-016-43246",null],["Reference","ocds-5wno2w-SIE-HE-1-2025-020-43246",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER CIA. LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 2 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES FUERZAS ARMADAS NO. 1», 219,991 USD (≈ $219,991); one bid; OCID ocds-5wno2w-RE-PU-HE-1-2024-016-43246, ocds-5wno2w-SIE-HE-1-2025-020-43246; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); buyer — security/fiscal body","entity":"f593f53b"},{"code":"W-01635","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · Hospital Eugenio Espejo","buyer":"","amount":212320.0,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-RE-PU-HEEE-2024-004-52558","2012-08-07"],"id":"W-01635","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01635/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01635/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER CIA. LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «Hospital Eugenio Espejo», 212,320 USD (≈ $212,320); one bid; OCID ocds-5wno2w-RE-PU-HEEE-2024-004-52558; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","PFE · SUB · EC · Hospital Eugenio Espejo",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","212,320",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01635",null],["Reference","ocds-5wno2w-RE-PU-HEEE-2024-004-52558",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER CIA. LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «Hospital Eugenio Espejo», 212,320 USD (≈ $212,320); one bid; OCID ocds-5wno2w-RE-PU-HEEE-2024-004-52558; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"260bd7af"},{"code":"W-01640","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"IBM · SUB · EC · EMPRESA ELÉCTRICA QUITO S.A. E.E.Q.","buyer":"","amount":203817.13,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-RE-PU-EEQ-2025-003-3214","2011-03-18"],"id":"W-01640","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01640/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01640/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «IBM DEL ECUADOR C.A.» ↔ SEC IBM (CIK 51143, INTERNATIONAL BUSINESS MACHINES CORP): 1 non-competitive contracts at the buyer «EMPRESA ELÉCTRICA QUITO S.A. E.E.Q.», 203,817 USD (≈ $203,817); one bid; OCID ocds-5wno2w-RE-PU-EEQ-2025-003-3214; ⚑ REPEAT: already sanctioned SEC by FCPA (2011-03-18 International Business Machines Corp.).","facts":[["Company / subject","IBM · SUB · EC · EMPRESA ELÉCTRICA QUITO S.A. E.E.Q.",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","203,817",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01640",null],["Reference","ocds-5wno2w-RE-PU-EEQ-2025-003-3214",null],["Reference","2011-03-18",null]],"summary":"subsidiary/issuer «IBM DEL ECUADOR C.A.» ↔ SEC IBM (CIK 51143, INTERNATIONAL BUSINESS MACHINES CORP): 1 non-competitive contracts at the buyer «EMPRESA ELÉCTRICA QUITO S.A. E.E.Q.», 203,817 USD (≈ $203,817); one bid; OCID ocds-5wno2w-RE-PU-EEQ-2025-003-3214; ⚑ REPEAT: already sanctioned SEC by FCPA (2011-03-18 International Business Machines Corp.)","entity":"14d75349"},{"code":"W-01627","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"LIN · SUB · EC · HOSPITAL DOCENTE DE AMBATO","buyer":"","amount":185717.1,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-HPDA-39-2021-2728","2021-10-06"],"id":"W-01627","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01627/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01627/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: LIN · SUB · EC · HOSPITAL DOCENTE DE AMBATO, 185,717.","facts":[["Company / subject","LIN · SUB · EC · HOSPITAL DOCENTE DE AMBATO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","185,717",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01627",null],["Reference","ocds-5wno2w-SIE-HPDA-39-2021-2728",null],["Reference","2021-10-06",null]],"summary":null,"entity":"f5712c8d"},{"code":"W-02851","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"BAX · SUB~ · EC · Hospital Quito No.1 de la Policia Nacional","buyer":"","amount":182997.25,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-HQ-INSU-029-2020-20291","2021-10-06"],"id":"W-02851","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02851/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02851/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: BAX · SUB~ · EC · Hospital Quito No.1 de la Policia Nacional, 182,997.","facts":[["Company / subject","BAX · SUB~ · EC · Hospital Quito No.1 de la Policia Nacional",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","182,997",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-02851",null],["Reference","ocds-5wno2w-SIE-HQ-INSU-029-2020-20291",null],["Reference","2021-10-06",null]],"summary":null,"entity":"19e698b4"},{"code":"W-01607","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL GENERAL - AMBATO","buyer":"","amount":174727.806,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210001964061-2764","ocds-5wno2w-CE-20220002129100-2764","ocds-5wno2w-CE-20220002129101-2764","2020-06-25","2016-03-23"],"id":"W-01607","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01607/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01607/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «HOSPITAL GENERAL - AMBATO», 174,728 USD (≈ $174,728); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001964061-2764, ocds-5wno2w-CE-20220002129100-2764, ocds-5wno2w-CE-20220002129101-2764; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL GENERAL - AMBATO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","174,728",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-01607",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210001964061-2764",null],["Reference","ocds-5wno2w-CE-20220002129100-2764",null],["Reference","ocds-5wno2w-CE-20220002129101-2764",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «HOSPITAL GENERAL - AMBATO», 174,728 USD (≈ $174,728); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001964061-2764, ocds-5wno2w-CE-20220002129100-2764, ocds-5wno2w-CE-20220002129101-2764; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"46e3ce37"},{"code":"W-01641","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"MRK · SUB · EC · Hospital Guayaquil Abel Gilbert Ponton","buyer":"","amount":170000.0,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-RE-PU-HAGP-2025-002-17993"],"id":"W-01641","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01641/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01641/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «MERCK SHARP AND DOHME (I.A) LLC» ↔ SEC MRK (CIK 310158, Merck & Co., Inc.): 1 non-competitive contracts at the buyer «Hospital Guayaquil Abel Gilbert Ponton», 170,000 USD (≈ $170,000); one bid; OCID ocds-5wno2w-RE-PU-HAGP-2025-002-17993; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","MRK · SUB · EC · Hospital Guayaquil Abel Gilbert Ponton",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","170,000",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01641",null],["Reference","ocds-5wno2w-RE-PU-HAGP-2025-002-17993",null]],"summary":"subsidiary/issuer «MERCK SHARP AND DOHME (I.A) LLC» ↔ SEC MRK (CIK 310158, Merck & Co., Inc.): 1 non-competitive contracts at the buyer «Hospital Guayaquil Abel Gilbert Ponton», 170,000 USD (≈ $170,000); one bid; OCID ocds-5wno2w-RE-PU-HAGP-2025-002-17993; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"3014f071"},{"code":"W-01637","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL DEL NIÑO FY","buyer":"","amount":163231.2,"currency":null,"records":1,"found":"2026-10-04","refs":["SICM-197-2016-C","ocds-5wno2w-CE-20250002778151-29399","2012-08-07"],"id":"W-01637","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01637/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01637/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER PFE CIA.LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «HOSPITAL DEL NIÑO FY», 163,231 USD (≈ $163,231); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20250002778151-29399; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL DEL NIÑO FY",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","163,231",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01637",null],["Reference","SICM-197-2016-C",null],["Reference","ocds-5wno2w-CE-20250002778151-29399",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER PFE CIA.LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «HOSPITAL DEL NIÑO FY», 163,231 USD (≈ $163,231); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20250002778151-29399; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"1708b90d"},{"code":"W-02872","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · MINISTERIO DE SALUD PUBLICA MATRIZ","buyer":"","amount":153251.65,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20260002969204-2455","ocds-5wno2w-CE-20260002969248-2455","ocds-5wno2w-CE-20260002969254-2455"],"id":"W-02872","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02872/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02872/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA MATRIZ», 153,252 USD (≈ $153,252); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20260002969204-2455, ocds-5wno2w-CE-20260002969248-2455, ocds-5wno2w-CE-20260002969254-2455; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · MINISTERIO DE SALUD PUBLICA MATRIZ",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","153,252",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-02872",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20260002969204-2455",null],["Reference","ocds-5wno2w-CE-20260002969248-2455",null],["Reference","ocds-5wno2w-CE-20260002969254-2455",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA MATRIZ», 153,252 USD (≈ $153,252); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20260002969204-2455, ocds-5wno2w-CE-20260002969248-2455, ocds-5wno2w-CE-20260002969254-2455; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"067778e0"},{"code":"W-02854","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"SNY · SUB~ · EC · HOSPITAL PEDIATRICO BACA ORTIZ","buyer":"","amount":140866.8,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-RE-HBO-014-2021-YA-40576","2018-09-04","2021-10-06"],"id":"W-02854","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02854/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02854/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: SNY · SUB~ · EC · HOSPITAL PEDIATRICO BACA ORTIZ, 140,867.","facts":[["Company / subject","SNY · SUB~ · EC · HOSPITAL PEDIATRICO BACA ORTIZ",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","140,867",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-02854",null],["Reference","ocds-5wno2w-RE-HBO-014-2021-YA-40576",null],["Reference","2018-09-04",null],["Reference","2021-10-06",null]],"summary":null,"entity":"c704ff65"},{"code":"W-01648","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN","buyer":"","amount":135200.0,"currency":null,"records":1,"found":"2026-10-04","refs":["SICM-428-2022","ocds-5wno2w-CE-20260003105159-54651","2012-08-07"],"id":"W-01648","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01648/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01648/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER CIA. LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN», 135,200 USD (≈ $135,200); method direct (Catálogo electrónico - Compra directa en el convenio SICM-428-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20260003105159-54651; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","135,200",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01648",null],["Reference","SICM-428-2022",null],["Reference","ocds-5wno2w-CE-20260003105159-54651",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER CIA. LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN», 135,200 USD (≈ $135,200); method direct (Catálogo electrónico - Compra directa en el convenio SICM-428-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20260003105159-54651; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"aa672a95"},{"code":"W-01620","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"STE · AGENT · EC · ANDRADE LARA JAVIER ROBERTO","buyer":"","amount":134012.56,"currency":null,"records":6,"found":"2026-10-04","refs":["ocds-5wno2w-RE-HGESDTC-003-2021-8531","ocds-5wno2w-RE-HGESDTC-004-2021-8531","ocds-5wno2w-SIE-HQ-DA-014-2021-20291","ocds-5wno2w-RE-PU-HDTC-2026-001-8531","ocds-5wno2w-SIE-HGMVI-2026-005-18615"],"id":"W-01620","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01620/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01620/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: intermediary «ANDRADE LARA JAVIER ROBERTO» supplies the brand STERIS ↔ SEC STE (CIK 1757898, STERIS plc): 6 non-competitive contracts, 134,013 USD (≈ $134,013); one bid; OCID ocds-5wno2w-RE-HGESDTC-003-2021-8531, ocds-5wno2w-RE-HGESDTC-004-2021-8531, ocds-5wno2w-SIE-HQ-DA-014-2021-20291, ocds-5wno2w-RE-PU-HDTC-2026-001-8531, ocds-5wno2w-SIE-HGMVI-2026-005-18615.","facts":[["Company / subject","STE · AGENT · EC · ANDRADE LARA JAVIER ROBERTO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","134,013",null],["Records behind the indicator","6",null],["Found","4 October 2026",null],["Code","W-01620",null],["Reference","ocds-5wno2w-RE-HGESDTC-003-2021-8531",null],["Reference","ocds-5wno2w-RE-HGESDTC-004-2021-8531",null],["Reference","ocds-5wno2w-SIE-HQ-DA-014-2021-20291",null],["Reference","ocds-5wno2w-RE-PU-HDTC-2026-001-8531",null],["Reference","ocds-5wno2w-SIE-HGMVI-2026-005-18615",null]],"summary":"intermediary «ANDRADE LARA JAVIER ROBERTO» supplies the brand STERIS ↔ SEC STE (CIK 1757898, STERIS plc): 6 non-competitive contracts, 134,013 USD (≈ $134,013); one bid; OCID ocds-5wno2w-RE-HGESDTC-003-2021-8531, ocds-5wno2w-RE-HGESDTC-004-2021-8531, ocds-5wno2w-SIE-HQ-DA-014-2021-20291, ocds-5wno2w-RE-PU-HDTC-2026-001-8531, ocds-5wno2w-SIE-HGMVI-2026-005-18615","entity":"4d1f65ae"},{"code":"W-01605","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL QUITO NO.1 DE LA POLICIA NACIONAL","buyer":"","amount":132740.79,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-198-2016-C","ocds-5wno2w-CE-20210001960343-20291","ocds-5wno2w-CE-20210001960372-20291","ocds-5wno2w-CE-20210001960373-20291","2012-08-07","2021-10-06"],"id":"W-01605","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01605/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01605/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: PFE · SUB · EC · HOSPITAL QUITO NO.1 DE LA POLICIA NACIONAL, 132,741.","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL QUITO NO.1 DE LA POLICIA NACIONAL",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","132,741",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-01605",null],["Reference","SICM-198-2016-C",null],["Reference","ocds-5wno2w-CE-20210001960343-20291",null],["Reference","ocds-5wno2w-CE-20210001960372-20291",null],["Reference","ocds-5wno2w-CE-20210001960373-20291",null],["Reference","2012-08-07",null],["Reference","2021-10-06",null]],"summary":null,"entity":"df833c71"},{"code":"W-01636","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GM · SUB · EC · EMPRESA PUBLICA MUNICIPAL PARA LA GESTION INTEGRAL DE LOS DESECHOS SOLIDOS DEL CANTON AMBATO","buyer":"","amount":123199.5,"currency":null,"records":1,"found":"2026-10-04","refs":["SERCOP-SELPROV-004-2021","ocds-5wno2w-CE-20250002777373-382149"],"id":"W-01636","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01636/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01636/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «OMNIBUS BB TRANSPORTES S.A.» ↔ SEC GM (CIK 1467858, General Motors Co): 1 non-competitive contracts at the buyer «EMPRESA PUBLICA MUNICIPAL PARA LA GESTION INTEGRAL DE LOS DESECHOS SOLIDOS DEL CANTON AMBATO», 123,200 USD (≈ $123,200); method selective (Catálogo electrónico - Gran compra mejor oferta en el convenio SERCOP-SELPROV-004-2021, VEHICULOS 2021, ADQUISICIÓN DE VEHÍCULOS QUE CUMPLAN CON EL PRINCIPIO DE VIGENCIA TECNOLÓGICA); OCID ocds-5wno2w-CE-20250002777373-382149; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GM · SUB · EC · EMPRESA PUBLICA MUNICIPAL PARA LA GESTION INTEGRAL DE LOS DESECHOS SOLIDOS DEL CANTON AMBATO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","123,200",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01636",null],["Reference","SERCOP-SELPROV-004-2021",null],["Reference","ocds-5wno2w-CE-20250002777373-382149",null]],"summary":"subsidiary/issuer «OMNIBUS BB TRANSPORTES S.A.» ↔ SEC GM (CIK 1467858, General Motors Co): 1 non-competitive contracts at the buyer «EMPRESA PUBLICA MUNICIPAL PARA LA GESTION INTEGRAL DE LOS DESECHOS SOLIDOS DEL CANTON AMBATO», 123,200 USD (≈ $123,200); method selective (Catálogo electrónico - Gran compra mejor oferta en el convenio SERCOP-SELPROV-004-2021, VEHICULOS 2021, ADQUISICIÓN DE VEHÍCULOS QUE CUMPLAN CON EL PRINCIPIO DE VIGENCIA TECNOLÓGICA); OCID ocds-5wno2w-CE-20250002777373-382149; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"36b69d50"},{"code":"W-01625","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"LIN · SUB · EC · HOSPITAL GENERAL LATACUNGA","buyer":"","amount":120382.1,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-HGL-051-2021-17082","2021-10-06"],"id":"W-01625","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01625/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01625/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: LIN · SUB · EC · HOSPITAL GENERAL LATACUNGA, 120,382.","facts":[["Company / subject","LIN · SUB · EC · HOSPITAL GENERAL LATACUNGA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","120,382",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01625",null],["Reference","ocds-5wno2w-SIE-HGL-051-2021-17082",null],["Reference","2021-10-06",null]],"summary":null,"entity":"d57964b9"},{"code":"W-01616","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL GENERAL IBARRA","buyer":"","amount":116933.2164,"currency":null,"records":1,"found":"2026-10-04","refs":["SICM-198-2016-C","ocds-5wno2w-CE-20210002056028-3260","2012-08-07","2021-10-06"],"id":"W-01616","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01616/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01616/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: PFE · SUB · EC · HOSPITAL GENERAL IBARRA, 116,933.","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL GENERAL IBARRA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","116,933",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01616",null],["Reference","SICM-198-2016-C",null],["Reference","ocds-5wno2w-CE-20210002056028-3260",null],["Reference","2012-08-07",null],["Reference","2021-10-06",null]],"summary":null,"entity":"7020b23b"},{"code":"W-01623","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"LIN · SUB · EC · Hospital Guayaquil Abel Gilbert Ponton","buyer":"","amount":116612.98,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-HAGP-024-2021-17993","2021-10-06"],"id":"W-01623","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01623/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01623/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: LIN · SUB · EC · Hospital Guayaquil Abel Gilbert Ponton, 116,613.","facts":[["Company / subject","LIN · SUB · EC · Hospital Guayaquil Abel Gilbert Ponton",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","116,613",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01623",null],["Reference","ocds-5wno2w-SIE-HAGP-024-2021-17993",null],["Reference","2021-10-06",null]],"summary":null,"entity":"87264f93"},{"code":"W-01643","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"TIGO · SUB · EC · CORPORACION ELECTRICA DEL ECUADOR CELEC EP.","buyer":"","amount":109630.02,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-CELECEP-2025-01021-238940"],"id":"W-01643","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01643/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01643/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «OTECEL S.A.» ↔ SEC TIGO (CIK 912958, MILLICOM INTERNATIONAL CELLULAR SA): 1 non-competitive contracts at the buyer «CORPORACION ELECTRICA DEL ECUADOR CELEC EP.», 109,630 USD (≈ $109,630); one bid; OCID ocds-5wno2w-SIE-CELECEP-2025-01021-238940.","facts":[["Company / subject","TIGO · SUB · EC · CORPORACION ELECTRICA DEL ECUADOR CELEC EP.",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","109,630",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01643",null],["Reference","ocds-5wno2w-SIE-CELECEP-2025-01021-238940",null]],"summary":"subsidiary/issuer «OTECEL S.A.» ↔ SEC TIGO (CIK 912958, MILLICOM INTERNATIONAL CELLULAR SA): 1 non-competitive contracts at the buyer «CORPORACION ELECTRICA DEL ECUADOR CELEC EP.», 109,630 USD (≈ $109,630); one bid; OCID ocds-5wno2w-SIE-CELECEP-2025-01021-238940","entity":"69cc52ce"},{"code":"W-01644","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"LIN · SUB · EC · HOSPITAL DE ESPECIALIDADES QUITO NO.1 DE LA POLICIA NACIONAL DEL ECUADOR","buyer":"","amount":107112.8,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-HEQN1-2025-014-20291"],"id":"W-01644","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01644/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01644/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «LINDE ECUADOR S.A.» ↔ SEC LIN (CIK 1707925, LINDE PLC): 1 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES QUITO NO.1 DE LA POLICIA NACIONAL DEL ECUADOR», 107,113 USD (≈ $107,113); one bid; OCID ocds-5wno2w-SIE-HEQN1-2025-014-20291; buyer — security/fiscal body.","facts":[["Company / subject","LIN · SUB · EC · HOSPITAL DE ESPECIALIDADES QUITO NO.1 DE LA POLICIA NACIONAL DEL ECUADOR",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","107,113",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01644",null],["Reference","ocds-5wno2w-SIE-HEQN1-2025-014-20291",null]],"summary":"subsidiary/issuer «LINDE ECUADOR S.A.» ↔ SEC LIN (CIK 1707925, LINDE PLC): 1 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES QUITO NO.1 DE LA POLICIA NACIONAL DEL ECUADOR», 107,113 USD (≈ $107,113); one bid; OCID ocds-5wno2w-SIE-HEQN1-2025-014-20291; buyer — security/fiscal body","entity":"09f47e0f"},{"code":"W-01594","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL VICENTE CORRAL MOSCOSO","buyer":"","amount":105147.48640000001,"currency":null,"records":4,"found":"2026-10-04","refs":["SICM-198-2016-C","ocds-5wno2w-CE-20210001953512-12070","ocds-5wno2w-CE-20210002017868-12070","ocds-5wno2w-CE-20220002132042-12070","ocds-5wno2w-CE-20250002780287-12070","2012-08-07"],"id":"W-01594","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01594/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01594/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER PFE CIA.LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 4 non-competitive contracts at the buyer «HOSPITAL VICENTE CORRAL MOSCOSO», 105,147 USD (≈ $105,147); method direct (Catálogo electrónico - Compra directa en el convenio SICM-198-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001953512-12070, ocds-5wno2w-CE-20210002017868-12070, ocds-5wno2w-CE-20220002132042-12070, ocds-5wno2w-CE-20250002780287-12070; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL VICENTE CORRAL MOSCOSO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","105,147",null],["Records behind the indicator","4",null],["Found","4 October 2026",null],["Code","W-01594",null],["Reference","SICM-198-2016-C",null],["Reference","ocds-5wno2w-CE-20210001953512-12070",null],["Reference","ocds-5wno2w-CE-20210002017868-12070",null],["Reference","ocds-5wno2w-CE-20220002132042-12070",null],["Reference","ocds-5wno2w-CE-20250002780287-12070",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER PFE CIA.LTDA. (+ more 1 legal entities of the family)» ↔ SEC PFE (CIK 78003, PFIZER INC): 4 non-competitive contracts at the buyer «HOSPITAL VICENTE CORRAL MOSCOSO», 105,147 USD (≈ $105,147); method direct (Catálogo electrónico - Compra directa en el convenio SICM-198-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001953512-12070, ocds-5wno2w-CE-20210002017868-12070, ocds-5wno2w-CE-20220002132042-12070, ocds-5wno2w-CE-20250002780287-12070; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"2deb41ae"},{"code":"W-01624","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"LIN · SUB · EC · HOSPITAL GENERAL MARCO VINICIO IZA","buyer":"","amount":102656.56,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-HGMVI-018-2021-18615","2021-10-06"],"id":"W-01624","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01624/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01624/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: LIN · SUB · EC · HOSPITAL GENERAL MARCO VINICIO IZA, 102,657.","facts":[["Company / subject","LIN · SUB · EC · HOSPITAL GENERAL MARCO VINICIO IZA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","102,657",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01624",null],["Reference","ocds-5wno2w-SIE-HGMVI-018-2021-18615",null],["Reference","2021-10-06",null]],"summary":null,"entity":"97255807"},{"code":"W-02850","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · ISSFA","buyer":"","amount":77786.7,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-RE-ISSFA-2021-004-2803","ocds-5wno2w-CE-20250002903977-2803"],"id":"W-02850","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02850/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02850/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «ISSFA», 77,787 USD (≈ $77,787); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTO; OCID ocds-5wno2w-RE-ISSFA-2021-004-2803, ocds-5wno2w-CE-20250002903977-2803.","facts":[["Company / subject","GSK · SUB~ · EC · ISSFA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","77,787",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02850",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-RE-ISSFA-2021-004-2803",null],["Reference","ocds-5wno2w-CE-20250002903977-2803",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «ISSFA», 77,787 USD (≈ $77,787); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTO; OCID ocds-5wno2w-RE-ISSFA-2021-004-2803, ocds-5wno2w-CE-20250002903977-2803","entity":"32f34981"},{"code":"W-01606","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · CENTRO DE ESPECIALIDADES CENTRAL GUAYAS","buyer":"","amount":76174.56,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-197-2016-C","ocds-5wno2w-CE-20210001960081-2739","ocds-5wno2w-CE-20240002561035-2739","2012-08-07"],"id":"W-01606","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01606/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01606/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER PFE CIA.LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 2 non-competitive contracts at the buyer «CENTRO DE ESPECIALIDADES CENTRAL GUAYAS», 76,175 USD (≈ $76,175); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001960081-2739, ocds-5wno2w-CE-20240002561035-2739; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","PFE · SUB · EC · CENTRO DE ESPECIALIDADES CENTRAL GUAYAS",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","76,175",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01606",null],["Reference","SICM-197-2016-C",null],["Reference","ocds-5wno2w-CE-20210001960081-2739",null],["Reference","ocds-5wno2w-CE-20240002561035-2739",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER PFE CIA.LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 2 non-competitive contracts at the buyer «CENTRO DE ESPECIALIDADES CENTRAL GUAYAS», 76,175 USD (≈ $76,175); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001960081-2739, ocds-5wno2w-CE-20240002561035-2739; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"e56e0cee"},{"code":"W-01639","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"TIGO · SUB · EC · DIRECCION NACIONAL DE INVESTIGACION ANTIDROGAS","buyer":"","amount":65080.32,"currency":null,"records":2,"found":"2026-10-04","refs":["ocds-5wno2w-RE-PU-DNA-2025-006-178618","ocds-5wno2w-RE-PU-DNA-2026-005-178618"],"id":"W-01639","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01639/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01639/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «OTECEL S.A.» ↔ SEC TIGO (CIK 912958, MILLICOM INTERNATIONAL CELLULAR SA): 2 non-competitive contracts at the buyer «DIRECCION NACIONAL DE INVESTIGACION ANTIDROGAS», 65,080 USD (≈ $65,080); one bid; OCID ocds-5wno2w-RE-PU-DNA-2025-006-178618, ocds-5wno2w-RE-PU-DNA-2026-005-178618.","facts":[["Company / subject","TIGO · SUB · EC · DIRECCION NACIONAL DE INVESTIGACION ANTIDROGAS",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","65,080",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01639",null],["Reference","ocds-5wno2w-RE-PU-DNA-2025-006-178618",null],["Reference","ocds-5wno2w-RE-PU-DNA-2026-005-178618",null]],"summary":"subsidiary/issuer «OTECEL S.A.» ↔ SEC TIGO (CIK 912958, MILLICOM INTERNATIONAL CELLULAR SA): 2 non-competitive contracts at the buyer «DIRECCION NACIONAL DE INVESTIGACION ANTIDROGAS», 65,080 USD (≈ $65,080); one bid; OCID ocds-5wno2w-RE-PU-DNA-2025-006-178618, ocds-5wno2w-RE-PU-DNA-2026-005-178618","entity":"eaaff0b4"},{"code":"W-02861","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · MINISTERIO DE SALUD PUBLICA - COORDINACION ZONAL 5","buyer":"","amount":64997.7,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-486-2022","ocds-5wno2w-CE-20240002571195-427936","ocds-5wno2w-CE-20240002573304-427936","ocds-5wno2w-CE-20240002573324-427936"],"id":"W-02861","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02861/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02861/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA - COORDINACION ZONAL 5», 64,998 USD (≈ $64,998); method direct (Catálogo electrónico - Compra directa en el convenio SICM-486-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20240002571195-427936, ocds-5wno2w-CE-20240002573304-427936, ocds-5wno2w-CE-20240002573324-427936; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · MINISTERIO DE SALUD PUBLICA - COORDINACION ZONAL 5",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","64,998",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-02861",null],["Reference","SICM-486-2022",null],["Reference","ocds-5wno2w-CE-20240002571195-427936",null],["Reference","ocds-5wno2w-CE-20240002573304-427936",null],["Reference","ocds-5wno2w-CE-20240002573324-427936",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA - COORDINACION ZONAL 5», 64,998 USD (≈ $64,998); method direct (Catálogo electrónico - Compra directa en el convenio SICM-486-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20240002571195-427936, ocds-5wno2w-CE-20240002573304-427936, ocds-5wno2w-CE-20240002573324-427936; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"0c359756"},{"code":"W-01604","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL QUITO NO.1 DE LA POLICIA NACIONAL","buyer":"","amount":53848.0,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210001960333-20291","ocds-5wno2w-CE-20210001960357-20291","2020-06-25","2016-03-23","2021-10-06"],"id":"W-01604","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01604/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01604/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: NVS · SUB · EC · HOSPITAL QUITO NO.1 DE LA POLICIA NACIONAL, 53,848.","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL QUITO NO.1 DE LA POLICIA NACIONAL",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","53,848",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01604",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210001960333-20291",null],["Reference","ocds-5wno2w-CE-20210001960357-20291",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null],["Reference","2021-10-06",null]],"summary":null,"entity":"5733b89d"},{"code":"W-01593","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL VICENTE CORRAL MOSCOSO","buyer":"","amount":41239.31999999999,"currency":null,"records":4,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210001953510-12070","ocds-5wno2w-CE-20210001953511-12070","ocds-5wno2w-CE-20210002050100-12070","ocds-5wno2w-CE-20220002132041-12070","2020-06-25","2016-03-23"],"id":"W-01593","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01593/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01593/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 4 non-competitive contracts at the buyer «HOSPITAL VICENTE CORRAL MOSCOSO», 41,239 USD (≈ $41,239); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001953510-12070, ocds-5wno2w-CE-20210001953511-12070, ocds-5wno2w-CE-20210002050100-12070, ocds-5wno2w-CE-20220002132041-12070; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL VICENTE CORRAL MOSCOSO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","41,239",null],["Records behind the indicator","4",null],["Found","4 October 2026",null],["Code","W-01593",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210001953510-12070",null],["Reference","ocds-5wno2w-CE-20210001953511-12070",null],["Reference","ocds-5wno2w-CE-20210002050100-12070",null],["Reference","ocds-5wno2w-CE-20220002132041-12070",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 4 non-competitive contracts at the buyer «HOSPITAL VICENTE CORRAL MOSCOSO», 41,239 USD (≈ $41,239); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001953510-12070, ocds-5wno2w-CE-20210001953511-12070, ocds-5wno2w-CE-20210002050100-12070, ocds-5wno2w-CE-20220002132041-12070; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"e35f3b33"},{"code":"W-01631","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"LIN · SUB · EC · HOSPITAL NAVAL GUAYAQUIL","buyer":"","amount":37407.89,"currency":null,"records":2,"found":"2026-10-04","refs":["ocds-5wno2w-SIE-HOSNAG-042-2021-2706","ocds-5wno2w-SIE-HOSNAG-2024-006-2706"],"id":"W-01631","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01631/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01631/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «LINDE ECUADOR S.A.» ↔ SEC LIN (CIK 1707925, LINDE PLC): 2 non-competitive contracts at the buyer «HOSPITAL NAVAL GUAYAQUIL», 37,408 USD (≈ $37,408); one bid; OCID ocds-5wno2w-SIE-HOSNAG-042-2021-2706, ocds-5wno2w-SIE-HOSNAG-2024-006-2706; buyer — security/fiscal body.","facts":[["Company / subject","LIN · SUB · EC · HOSPITAL NAVAL GUAYAQUIL",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","37,408",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01631",null],["Reference","ocds-5wno2w-SIE-HOSNAG-042-2021-2706",null],["Reference","ocds-5wno2w-SIE-HOSNAG-2024-006-2706",null]],"summary":"subsidiary/issuer «LINDE ECUADOR S.A.» ↔ SEC LIN (CIK 1707925, LINDE PLC): 2 non-competitive contracts at the buyer «HOSPITAL NAVAL GUAYAQUIL», 37,408 USD (≈ $37,408); one bid; OCID ocds-5wno2w-SIE-HOSNAG-042-2021-2706, ocds-5wno2w-SIE-HOSNAG-2024-006-2706; buyer — security/fiscal body","entity":"375f79d7"},{"code":"W-02863","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL DOCENTE DE AMBATO","buyer":"","amount":37365.775,"currency":null,"records":6,"found":"2026-10-04","refs":["SICM-430-2022","ocds-5wno2w-CE-20240002576170-2728","ocds-5wno2w-CE-20240002576189-2728","ocds-5wno2w-CE-20250002784415-2728","ocds-5wno2w-CE-20250002784457-2728","ocds-5wno2w-CE-20250002788198-2728","ocds-5wno2w-CE-20250002788883-2728"],"id":"W-02863","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02863/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02863/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 6 non-competitive contracts at the buyer «HOSPITAL DOCENTE DE AMBATO», 37,366 USD (≈ $37,366); method direct (Catálogo electrónico - Compra directa en el convenio SICM-430-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20240002576170-2728, ocds-5wno2w-CE-20240002576189-2728, ocds-5wno2w-CE-20250002784415-2728, ocds-5wno2w-CE-20250002784457-2728, ocds-5wno2w-CE-20250002788198-2728, ocds-5wno2w-CE-20250002788883-2728; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL DOCENTE DE AMBATO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","37,366",null],["Records behind the indicator","6",null],["Found","4 October 2026",null],["Code","W-02863",null],["Reference","SICM-430-2022",null],["Reference","ocds-5wno2w-CE-20240002576170-2728",null],["Reference","ocds-5wno2w-CE-20240002576189-2728",null],["Reference","ocds-5wno2w-CE-20250002784415-2728",null],["Reference","ocds-5wno2w-CE-20250002784457-2728",null],["Reference","ocds-5wno2w-CE-20250002788198-2728",null],["Reference","ocds-5wno2w-CE-20250002788883-2728",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 6 non-competitive contracts at the buyer «HOSPITAL DOCENTE DE AMBATO», 37,366 USD (≈ $37,366); method direct (Catálogo electrónico - Compra directa en el convenio SICM-430-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20240002576170-2728, ocds-5wno2w-CE-20240002576189-2728, ocds-5wno2w-CE-20250002784415-2728, ocds-5wno2w-CE-20250002784457-2728, ocds-5wno2w-CE-20250002788198-2728, ocds-5wno2w-CE-20250002788883-2728; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"b378af46"},{"code":"W-01628","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"CIB · SUB~ · EC · EL MERCURIO CIA LTDA","buyer":"","amount":33444.5,"currency":null,"records":2,"found":"2026-10-04","refs":["ocds-5wno2w-RE-UC-004-2021-30951","ocds-5wno2w-RE-CSCD-CEMA-2026-001-29813"],"id":"W-01628","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01628/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01628/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'P A MERCURIO ~0.88' «EL MERCURIO CIA LTDA» ↔ SEC CIB (CIK 2058897, Grupo Cibest S.A.): 2 non-competitive contracts at the buyer «UNIVERSIDAD DE CUENCA», 33,444 USD (≈ $33,444); one bid; OCID ocds-5wno2w-RE-UC-004-2021-30951, ocds-5wno2w-RE-CSCD-CEMA-2026-001-29813.","facts":[["Company / subject","CIB · SUB~ · EC · EL MERCURIO CIA LTDA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","33,444",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01628",null],["Reference","ocds-5wno2w-RE-UC-004-2021-30951",null],["Reference","ocds-5wno2w-RE-CSCD-CEMA-2026-001-29813",null]],"summary":"looks like a subsidiary 'P A MERCURIO ~0.88' «EL MERCURIO CIA LTDA» ↔ SEC CIB (CIK 2058897, Grupo Cibest S.A.): 2 non-competitive contracts at the buyer «UNIVERSIDAD DE CUENCA», 33,444 USD (≈ $33,444); one bid; OCID ocds-5wno2w-RE-UC-004-2021-30951, ocds-5wno2w-RE-CSCD-CEMA-2026-001-29813","entity":"8bff62d4"},{"code":"W-02864","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA","buyer":"","amount":32304.375,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20250002777755-87497","ocds-5wno2w-CE-20250002777781-87497","ocds-5wno2w-CE-20250002777782-87497"],"id":"W-02864","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02864/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02864/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA», 32,304 USD (≈ $32,304); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002777755-87497, ocds-5wno2w-CE-20250002777781-87497, ocds-5wno2w-CE-20250002777782-87497; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","32,304",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-02864",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20250002777755-87497",null],["Reference","ocds-5wno2w-CE-20250002777781-87497",null],["Reference","ocds-5wno2w-CE-20250002777782-87497",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES JOSÉ CARRASCO ARTEAGA», 32,304 USD (≈ $32,304); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002777755-87497, ocds-5wno2w-CE-20250002777781-87497, ocds-5wno2w-CE-20250002777782-87497; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"9ce24ce7"},{"code":"W-01615","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL GENERAL IBARRA","buyer":"","amount":29952.256,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210002056026-3260","ocds-5wno2w-CE-20210002056027-3260","2020-06-25","2016-03-23","2021-10-06"],"id":"W-01615","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01615/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01615/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: NVS · SUB · EC · HOSPITAL GENERAL IBARRA, 29,952.","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL GENERAL IBARRA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","29,952",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01615",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210002056026-3260",null],["Reference","ocds-5wno2w-CE-20210002056027-3260",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null],["Reference","2021-10-06",null]],"summary":null,"entity":"f14c6a16"},{"code":"W-02853","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL VICENTE CORRAL MOSCOSO","buyer":"","amount":16586.35,"currency":null,"records":4,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20220002132015-12070","ocds-5wno2w-CE-20250002780291-12070","ocds-5wno2w-CE-20250002780272-12070","ocds-5wno2w-CE-20250002780273-12070"],"id":"W-02853","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02853/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02853/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 4 non-competitive contracts at the buyer «HOSPITAL VICENTE CORRAL MOSCOSO», 16,586 USD (≈ $16,586); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20220002132015-12070, ocds-5wno2w-CE-20250002780291-12070, ocds-5wno2w-CE-20250002780272-12070, ocds-5wno2w-CE-20250002780273-12070; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL VICENTE CORRAL MOSCOSO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","16,586",null],["Records behind the indicator","4",null],["Found","4 October 2026",null],["Code","W-02853",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20220002132015-12070",null],["Reference","ocds-5wno2w-CE-20250002780291-12070",null],["Reference","ocds-5wno2w-CE-20250002780272-12070",null],["Reference","ocds-5wno2w-CE-20250002780273-12070",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 4 non-competitive contracts at the buyer «HOSPITAL VICENTE CORRAL MOSCOSO», 16,586 USD (≈ $16,586); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20220002132015-12070, ocds-5wno2w-CE-20250002780291-12070, ocds-5wno2w-CE-20250002780272-12070, ocds-5wno2w-CE-20250002780273-12070; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"ab2b1ae0"},{"code":"W-02859","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL SAN FRANCISCO DE QUITO","buyer":"","amount":13722.4,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20240002565442-390394","ocds-5wno2w-CE-20240002565443-390394"],"id":"W-02859","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02859/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02859/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL SAN FRANCISCO DE QUITO», 13,722 USD (≈ $13,722); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002565442-390394, ocds-5wno2w-CE-20240002565443-390394; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL SAN FRANCISCO DE QUITO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","13,722",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02859",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20240002565442-390394",null],["Reference","ocds-5wno2w-CE-20240002565443-390394",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL SAN FRANCISCO DE QUITO», 13,722 USD (≈ $13,722); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002565442-390394, ocds-5wno2w-CE-20240002565443-390394; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"ec2b1bbb"},{"code":"W-01638","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL HOMERO CASTANIER CRESPO","buyer":"","amount":13041.6,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM2-628-2016","ocds-5wno2w-CE-20250002786283-8380","ocds-5wno2w-CE-20250002902036-8380","2020-06-25","2016-03-23"],"id":"W-01638","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01638/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01638/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «HOSPITAL HOMERO CASTANIER CRESPO», 13,042 USD (≈ $13,042); method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20250002786283-8380, ocds-5wno2w-CE-20250002902036-8380; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL HOMERO CASTANIER CRESPO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","13,042",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01638",null],["Reference","SICM2-628-2016",null],["Reference","ocds-5wno2w-CE-20250002786283-8380",null],["Reference","ocds-5wno2w-CE-20250002902036-8380",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «HOSPITAL HOMERO CASTANIER CRESPO», 13,042 USD (≈ $13,042); method direct (Catálogo electrónico - Compra directa en el convenio SICM2-628-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCION DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20250002786283-8380, ocds-5wno2w-CE-20250002902036-8380; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"2fe10920"},{"code":"W-02860","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL GÍNECO OBSTÉTRICO PEDIÁTRICO DE NUEVA AURORA LUZ ELENA ARISMENDI","buyer":"","amount":6567.25,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20240002567769-730708","ocds-5wno2w-CE-20250002789002-730708","ocds-5wno2w-CE-20250002789003-730708"],"id":"W-02860","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02860/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02860/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «HOSPITAL GÍNECO OBSTÉTRICO PEDIÁTRICO DE NUEVA AURORA LUZ ELENA ARISMENDI», 6,567 USD (≈ $6,567); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002567769-730708, ocds-5wno2w-CE-20250002789002-730708, ocds-5wno2w-CE-20250002789003-730708; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL GÍNECO OBSTÉTRICO PEDIÁTRICO DE NUEVA AURORA LUZ ELENA ARISMENDI",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","6,567",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-02860",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20240002567769-730708",null],["Reference","ocds-5wno2w-CE-20250002789002-730708",null],["Reference","ocds-5wno2w-CE-20250002789003-730708",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «HOSPITAL GÍNECO OBSTÉTRICO PEDIÁTRICO DE NUEVA AURORA LUZ ELENA ARISMENDI», 6,567 USD (≈ $6,567); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002567769-730708, ocds-5wno2w-CE-20250002789002-730708, ocds-5wno2w-CE-20250002789003-730708; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"900681f6"},{"code":"W-02867","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL GENERAL LATACUNGA","buyer":"","amount":5828.5,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20250002786749-17082","ocds-5wno2w-CE-20250002786750-17082"],"id":"W-02867","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02867/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02867/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL GENERAL LATACUNGA», 5,828 USD (≈ $5,828); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002786749-17082, ocds-5wno2w-CE-20250002786750-17082; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL GENERAL LATACUNGA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","5,828",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02867",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20250002786749-17082",null],["Reference","ocds-5wno2w-CE-20250002786750-17082",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL GENERAL LATACUNGA», 5,828 USD (≈ $5,828); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002786749-17082, ocds-5wno2w-CE-20250002786750-17082; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"6b4a5253"},{"code":"W-02846","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL BASICO - DURAN","buyer":"","amount":5282.2,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20210001966081-59830","ocds-5wno2w-CE-20240002574259-59830"],"id":"W-02846","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02846/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02846/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL BASICO - DURAN», 5,282 USD (≈ $5,282); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20210001966081-59830, ocds-5wno2w-CE-20240002574259-59830; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL BASICO - DURAN",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","5,282",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02846",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20210001966081-59830",null],["Reference","ocds-5wno2w-CE-20240002574259-59830",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL BASICO - DURAN», 5,282 USD (≈ $5,282); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20210001966081-59830, ocds-5wno2w-CE-20240002574259-59830; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"1b6b7858"},{"code":"W-01611","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL GENERAL RODRIGUEZ ZAMBRANO","buyer":"","amount":4658.088,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210002011833-10269","ocds-5wno2w-CE-20210002011865-10269","2020-06-25","2016-03-23","2021-10-06"],"id":"W-01611","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01611/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01611/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: NVS · SUB · EC · HOSPITAL GENERAL RODRIGUEZ ZAMBRANO, 4,658.","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL GENERAL RODRIGUEZ ZAMBRANO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","4,658",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01611",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210002011833-10269",null],["Reference","ocds-5wno2w-CE-20210002011865-10269",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null],["Reference","2021-10-06",null]],"summary":null,"entity":"65572a99"},{"code":"W-02857","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL GÍNECO OBSTÉTRICO ISIDRO AYORA","buyer":"","amount":4371.375,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20240002562922-49010","ocds-5wno2w-CE-20240002565650-49010"],"id":"W-02857","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02857/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02857/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL GÍNECO OBSTÉTRICO ISIDRO AYORA», 4,371 USD (≈ $4,371); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002562922-49010, ocds-5wno2w-CE-20240002565650-49010; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL GÍNECO OBSTÉTRICO ISIDRO AYORA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","4,371",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02857",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20240002562922-49010",null],["Reference","ocds-5wno2w-CE-20240002565650-49010",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL GÍNECO OBSTÉTRICO ISIDRO AYORA», 4,371 USD (≈ $4,371); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002562922-49010, ocds-5wno2w-CE-20240002565650-49010; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"bb33dfeb"},{"code":"W-02856","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL GENERAL-BABAHOYO","buyer":"","amount":4124.05,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20240002560521-102124","ocds-5wno2w-CE-20240002560522-102124"],"id":"W-02856","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02856/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02856/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL GENERAL-BABAHOYO», 4,124 USD (≈ $4,124); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002560521-102124, ocds-5wno2w-CE-20240002560522-102124; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL GENERAL-BABAHOYO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","4,124",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02856",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20240002560521-102124",null],["Reference","ocds-5wno2w-CE-20240002560522-102124",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL GENERAL-BABAHOYO», 4,124 USD (≈ $4,124); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002560521-102124, ocds-5wno2w-CE-20240002560522-102124; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"04fedb0b"},{"code":"W-01610","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · CENTRO CLINICO QUIRURGICO AMBULATORIO (HOSPITAL DEL DIA) - MACAS","buyer":"","amount":3739.32,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210001965976-84474","ocds-5wno2w-CE-20220002129508-84474","2020-06-25","2016-03-23"],"id":"W-01610","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01610/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01610/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «CENTRO CLINICO QUIRURGICO AMBULATORIO (HOSPITAL DEL DIA) - MACAS», 3,739 USD (≈ $3,739); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001965976-84474, ocds-5wno2w-CE-20220002129508-84474; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · CENTRO CLINICO QUIRURGICO AMBULATORIO (HOSPITAL DEL DIA) - MACAS",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","3,739",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01610",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210001965976-84474",null],["Reference","ocds-5wno2w-CE-20220002129508-84474",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «CENTRO CLINICO QUIRURGICO AMBULATORIO (HOSPITAL DEL DIA) - MACAS», 3,739 USD (≈ $3,739); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001965976-84474, ocds-5wno2w-CE-20220002129508-84474; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"024954be"},{"code":"W-02866","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL MATILDE HIDALGO DE PROCEL","buyer":"","amount":3540.9,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-430-2022","ocds-5wno2w-CE-20250002785258-11080","ocds-5wno2w-CE-20250002785274-11080"],"id":"W-02866","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02866/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02866/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL MATILDE HIDALGO DE PROCEL», 3,541 USD (≈ $3,541); method direct (Catálogo electrónico - Compra directa en el convenio SICM-430-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20250002785258-11080, ocds-5wno2w-CE-20250002785274-11080; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL MATILDE HIDALGO DE PROCEL",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","3,541",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02866",null],["Reference","SICM-430-2022",null],["Reference","ocds-5wno2w-CE-20250002785258-11080",null],["Reference","ocds-5wno2w-CE-20250002785274-11080",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL MATILDE HIDALGO DE PROCEL», 3,541 USD (≈ $3,541); method direct (Catálogo electrónico - Compra directa en el convenio SICM-430-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20250002785258-11080, ocds-5wno2w-CE-20250002785274-11080; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"524da590"},{"code":"W-02869","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL BASICO ANCON","buyer":"","amount":2766.15,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20250002787567-84548","ocds-5wno2w-CE-20250002787568-84548"],"id":"W-02869","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02869/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02869/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL BASICO ANCON», 2,766 USD (≈ $2,766); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002787567-84548, ocds-5wno2w-CE-20250002787568-84548; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL BASICO ANCON",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","2,766",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02869",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20250002787567-84548",null],["Reference","ocds-5wno2w-CE-20250002787568-84548",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL BASICO ANCON», 2,766 USD (≈ $2,766); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002787567-84548, ocds-5wno2w-CE-20250002787568-84548; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"bdbb310e"},{"code":"W-01609","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · CENTROCLÍNICO QUIRÚRGICO AMBULATORIO HOSPITAL DEL DÍA - EL TENA","buyer":"","amount":2674.0132999999996,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210001965406-99953","ocds-5wno2w-CE-20210002042644-99953","2020-06-25","2016-03-23","2021-10-06"],"id":"W-01609","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01609/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01609/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: NVS · SUB · EC · CENTROCLÍNICO QUIRÚRGICO AMBULATORIO HOSPITAL DEL DÍA - EL TENA, 2,674.","facts":[["Company / subject","NVS · SUB · EC · CENTROCLÍNICO QUIRÚRGICO AMBULATORIO HOSPITAL DEL DÍA - EL TENA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","2,674",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01609",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210001965406-99953",null],["Reference","ocds-5wno2w-CE-20210002042644-99953",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null],["Reference","2021-10-06",null]],"summary":null,"entity":"1646f759"},{"code":"W-01612","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · CENTRO DE SALUD C-MATERNO INFANTIL Y EMERGENCIA-BAHIA DE CARAQUEZ","buyer":"","amount":2080.596,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210002018682-103495","ocds-5wno2w-CE-20210002051904-103495","2020-06-25","2016-03-23","2021-10-06"],"id":"W-01612","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01612/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01612/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: NVS · SUB · EC · CENTRO DE SALUD C-MATERNO INFANTIL Y EMERGENCIA-BAHIA DE CARAQUEZ, 2,081.","facts":[["Company / subject","NVS · SUB · EC · CENTRO DE SALUD C-MATERNO INFANTIL Y EMERGENCIA-BAHIA DE CARAQUEZ",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","2,081",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01612",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210002018682-103495",null],["Reference","ocds-5wno2w-CE-20210002051904-103495",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null],["Reference","2021-10-06",null]],"summary":null,"entity":"f7821168"},{"code":"W-02852","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL BÁSICO AIDA LEÓN DE RODRÍGUEZ LARA","buyer":"","amount":2069.7,"currency":null,"records":3,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20220002131090-134008","ocds-5wno2w-CE-20240002573493-134008","ocds-5wno2w-CE-20250002775594-134008"],"id":"W-02852","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02852/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02852/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «HOSPITAL BÁSICO AIDA LEÓN DE RODRÍGUEZ LARA», 2,070 USD (≈ $2,070); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20220002131090-134008, ocds-5wno2w-CE-20240002573493-134008, ocds-5wno2w-CE-20250002775594-134008; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL BÁSICO AIDA LEÓN DE RODRÍGUEZ LARA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","2,070",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-02852",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20220002131090-134008",null],["Reference","ocds-5wno2w-CE-20240002573493-134008",null],["Reference","ocds-5wno2w-CE-20250002775594-134008",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «HOSPITAL BÁSICO AIDA LEÓN DE RODRÍGUEZ LARA», 2,070 USD (≈ $2,070); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20220002131090-134008, ocds-5wno2w-CE-20240002573493-134008, ocds-5wno2w-CE-20250002775594-134008; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"c2d07b55"},{"code":"W-02870","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DÍA CENTRAL QUITO","buyer":"","amount":2004.5,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20250002905646-2807","ocds-5wno2w-CE-20250002905647-2807"],"id":"W-02870","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02870/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02870/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DÍA CENTRAL QUITO», 2,004 USD (≈ $2,004); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002905646-2807, ocds-5wno2w-CE-20250002905647-2807; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DÍA CENTRAL QUITO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","2,004",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02870",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20250002905646-2807",null],["Reference","ocds-5wno2w-CE-20250002905647-2807",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DÍA CENTRAL QUITO», 2,004 USD (≈ $2,004); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002905646-2807, ocds-5wno2w-CE-20250002905647-2807; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"de819f25"},{"code":"W-02862","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA AZOGUES","buyer":"","amount":1917.0,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20240002572941-97105","ocds-5wno2w-CE-20240002572951-97105"],"id":"W-02862","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02862/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02862/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA AZOGUES», 1,917 USD (≈ $1,917); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002572941-97105, ocds-5wno2w-CE-20240002572951-97105; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA AZOGUES",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,917",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02862",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20240002572941-97105",null],["Reference","ocds-5wno2w-CE-20240002572951-97105",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA AZOGUES», 1,917 USD (≈ $1,917); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002572941-97105, ocds-5wno2w-CE-20240002572951-97105; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"992453b2"},{"code":"W-02845","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · CENTRO DE SALUD A - SANTA CRUZ","buyer":"","amount":1694.2,"currency":null,"records":4,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20210001956299-107425","ocds-5wno2w-CE-20220002130214-107425","ocds-5wno2w-CE-20240002562322-107425","ocds-5wno2w-CE-20240002562323-107425"],"id":"W-02845","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02845/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02845/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 4 non-competitive contracts at the buyer «CENTRO DE SALUD A - SANTA CRUZ», 1,694 USD (≈ $1,694); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20210001956299-107425, ocds-5wno2w-CE-20220002130214-107425, ocds-5wno2w-CE-20240002562322-107425, ocds-5wno2w-CE-20240002562323-107425; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · CENTRO DE SALUD A - SANTA CRUZ",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,694",null],["Records behind the indicator","4",null],["Found","4 October 2026",null],["Code","W-02845",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20210001956299-107425",null],["Reference","ocds-5wno2w-CE-20220002130214-107425",null],["Reference","ocds-5wno2w-CE-20240002562322-107425",null],["Reference","ocds-5wno2w-CE-20240002562323-107425",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 4 non-competitive contracts at the buyer «CENTRO DE SALUD A - SANTA CRUZ», 1,694 USD (≈ $1,694); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20210001956299-107425, ocds-5wno2w-CE-20220002130214-107425, ocds-5wno2w-CE-20240002562322-107425, ocds-5wno2w-CE-20240002562323-107425; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"a71c5baa"},{"code":"W-01596","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · CENTRO DE SALUD A - BAÑOS","buyer":"","amount":1240.048,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210001954749-72588","ocds-5wno2w-CE-20220002128349-72588","2020-06-25","2016-03-23"],"id":"W-01596","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01596/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01596/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «CENTRO DE SALUD A - BAÑOS», 1,240 USD (≈ $1,240); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001954749-72588, ocds-5wno2w-CE-20220002128349-72588; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · CENTRO DE SALUD A - BAÑOS",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,240",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01596",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210001954749-72588",null],["Reference","ocds-5wno2w-CE-20220002128349-72588",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «CENTRO DE SALUD A - BAÑOS», 1,240 USD (≈ $1,240); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001954749-72588, ocds-5wno2w-CE-20220002128349-72588; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"56333e88"},{"code":"W-02868","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL HOMERO CASTANIER CRESPO","buyer":"","amount":1109.25,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-430-2022","ocds-5wno2w-CE-20250002786220-8380","ocds-5wno2w-CE-20250002786569-8380"],"id":"W-02868","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02868/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02868/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL HOMERO CASTANIER CRESPO», 1,109 USD (≈ $1,109); method direct (Catálogo electrónico - Compra directa en el convenio SICM-430-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20250002786220-8380, ocds-5wno2w-CE-20250002786569-8380; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL HOMERO CASTANIER CRESPO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,109",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02868",null],["Reference","SICM-430-2022",null],["Reference","ocds-5wno2w-CE-20250002786220-8380",null],["Reference","ocds-5wno2w-CE-20250002786569-8380",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL HOMERO CASTANIER CRESPO», 1,109 USD (≈ $1,109); method direct (Catálogo electrónico - Compra directa en el convenio SICM-430-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20250002786220-8380, ocds-5wno2w-CE-20250002786569-8380; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"49a0869a"},{"code":"W-01608","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · CENTRO DE SALUD A - PILLARO","buyer":"","amount":1041.896,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210001964464-84345","ocds-5wno2w-CE-20210002021460-84345","2020-06-25","2016-03-23","2021-10-06"],"id":"W-01608","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01608/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01608/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: NVS · SUB · EC · CENTRO DE SALUD A - PILLARO, 1,042.","facts":[["Company / subject","NVS · SUB · EC · CENTRO DE SALUD A - PILLARO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,042",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01608",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210001964464-84345",null],["Reference","ocds-5wno2w-CE-20210002021460-84345",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null],["Reference","2021-10-06",null]],"summary":null,"entity":"7037693e"},{"code":"W-01613","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · DIRECCION DISTRITAL 16D01 - PASTAZA - MERA - SANTA CLARA - SALUD","buyer":"","amount":645.592,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210002052500-44928","ocds-5wno2w-CE-20220002132360-44928","2020-06-25","2016-03-23"],"id":"W-01613","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01613/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01613/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «DIRECCION DISTRITAL 16D01 - PASTAZA - MERA - SANTA CLARA - SALUD», 646 USD (≈ $646); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210002052500-44928, ocds-5wno2w-CE-20220002132360-44928; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · DIRECCION DISTRITAL 16D01 - PASTAZA - MERA - SANTA CLARA - SALUD",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","646",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01613",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210002052500-44928",null],["Reference","ocds-5wno2w-CE-20220002132360-44928",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «DIRECCION DISTRITAL 16D01 - PASTAZA - MERA - SANTA CLARA - SALUD», 646 USD (≈ $646); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210002052500-44928, ocds-5wno2w-CE-20220002132360-44928; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"b0492456"},{"code":"W-01597","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · CENTRO DE SALUD A - SANTA CRUZ","buyer":"","amount":544.7582,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210001956308-107425","ocds-5wno2w-CE-20220002130221-107425","2020-06-25","2016-03-23"],"id":"W-01597","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01597/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01597/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «CENTRO DE SALUD A - SANTA CRUZ», 545 USD (≈ $545); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001956308-107425, ocds-5wno2w-CE-20220002130221-107425; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · CENTRO DE SALUD A - SANTA CRUZ",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","545",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01597",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210001956308-107425",null],["Reference","ocds-5wno2w-CE-20220002130221-107425",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «CENTRO DE SALUD A - SANTA CRUZ», 545 USD (≈ $545); method direct (Catálogo electrónico - Compra directa en el convenio SICM-047-2016, ADQUISICION DE CATALOGO DE MEDICAMENTOS, ?SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOS DE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001956308-107425, ocds-5wno2w-CE-20220002130221-107425; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"6dcd77f8"},{"code":"W-01603","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · CENTRO DE SALUD B - ALAUSI","buyer":"","amount":383.6798,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210001959011-93558","ocds-5wno2w-CE-20210002048278-93558","2020-06-25","2016-03-23","2021-10-06"],"id":"W-01603","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01603/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01603/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: NVS · SUB · EC · CENTRO DE SALUD B - ALAUSI, 384.","facts":[["Company / subject","NVS · SUB · EC · CENTRO DE SALUD B - ALAUSI",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","384",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01603",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210001959011-93558",null],["Reference","ocds-5wno2w-CE-20210002048278-93558",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null],["Reference","2021-10-06",null]],"summary":null,"entity":"9a98e98a"},{"code":"W-01614","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · BRIGADA DE INFANTERIA N 7 LOJA","buyer":"","amount":351.56,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-047-2016","ocds-5wno2w-CE-20210002055118-93521","ocds-5wno2w-CE-20210002056778-93521","2020-06-25","2016-03-23","2021-10-06"],"id":"W-01614","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01614/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01614/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: NVS · SUB · EC · BRIGADA DE INFANTERIA N 7 LOJA, 352.","facts":[["Company / subject","NVS · SUB · EC · BRIGADA DE INFANTERIA N 7 LOJA",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","352",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01614",null],["Reference","SICM-047-2016",null],["Reference","ocds-5wno2w-CE-20210002055118-93521",null],["Reference","ocds-5wno2w-CE-20210002056778-93521",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null],["Reference","2021-10-06",null]],"summary":null,"entity":"edaff56b"},{"code":"W-02865","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · HOSPITAL OBSTETRICO \"ANGELA LOAYZA DE OLLAGUE\"","buyer":"","amount":344.65,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20250002783125-141697","ocds-5wno2w-CE-20250002783367-141697"],"id":"W-02865","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02865/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02865/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL OBSTETRICO \"ANGELA LOAYZA DE OLLAGUE\"», 345 USD (≈ $345); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002783125-141697, ocds-5wno2w-CE-20250002783367-141697; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · HOSPITAL OBSTETRICO \"ANGELA LOAYZA DE OLLAGUE\"",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","345",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02865",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20250002783125-141697",null],["Reference","ocds-5wno2w-CE-20250002783367-141697",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL OBSTETRICO \"ANGELA LOAYZA DE OLLAGUE\"», 345 USD (≈ $345); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20250002783125-141697, ocds-5wno2w-CE-20250002783367-141697; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"2f48fdde"},{"code":"W-02844","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · CENTRO DE SALUD A - BAÑOS","buyer":"","amount":290.0,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-646-2011","ocds-5wno2w-CE-20210001954739-72588","ocds-5wno2w-CE-20220002128338-72588"],"id":"W-02844","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02844/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02844/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «CENTRO DE SALUD A - BAÑOS», 290 USD (≈ $290); method direct (Catálogo electrónico - Compra directa en el convenio SICM-646-2011, ADQUISICION DE REPERTORIO DE MEDICAMENTOS, Selección de proveedores para la provisión de medicamentos a publicarse en; OCID ocds-5wno2w-CE-20210001954739-72588, ocds-5wno2w-CE-20220002128338-72588; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · CENTRO DE SALUD A - BAÑOS",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","290",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02844",null],["Reference","SICM-646-2011",null],["Reference","ocds-5wno2w-CE-20210001954739-72588",null],["Reference","ocds-5wno2w-CE-20220002128338-72588",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «CENTRO DE SALUD A - BAÑOS», 290 USD (≈ $290); method direct (Catálogo electrónico - Compra directa en el convenio SICM-646-2011, ADQUISICION DE REPERTORIO DE MEDICAMENTOS, Selección de proveedores para la provisión de medicamentos a publicarse en; OCID ocds-5wno2w-CE-20210001954739-72588, ocds-5wno2w-CE-20220002128338-72588; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"555e071e"},{"code":"W-02858","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · EC · CENTRO DE SALUD B - EL ANGEL","buyer":"","amount":82.6,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-366-2022-A","ocds-5wno2w-CE-20240002563332-120022","ocds-5wno2w-CE-20250002785035-120022"],"id":"W-02858","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02858/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-02858/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «CENTRO DE SALUD B - EL ANGEL», 83 USD (≈ $83); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002563332-120022, ocds-5wno2w-CE-20250002785035-120022; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","GSK · SUB~ · EC · CENTRO DE SALUD B - EL ANGEL",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","83",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02858",null],["Reference","SICM-366-2022-A",null],["Reference","ocds-5wno2w-CE-20240002563332-120022",null],["Reference","ocds-5wno2w-CE-20250002785035-120022",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «CENTRO DE SALUD B - EL ANGEL», 83 USD (≈ $83); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002563332-120022, ocds-5wno2w-CE-20250002785035-120022; ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"a25c7008"}]}